ABC | Volume 110, Nº5, May 2018

Original Article Salmazo et al Frequency of subclinical atherosclerosis in Brazilian HIV-infected patients Arq Bras Cardiol. 2018; 110(5):402-410 10. Kaplana R, Kingsley L, Ganged S, Benning L, Jacobson L, Lazar J, et al. LowCD4R T-cell count as amajor atherosclerosis risk factor inHIV‑infected women and men. AIDS. 2008;22(13):1615-24. doi: 10.1097/ QAD.0b013e328300581d. 11. da Silva EF, Fonseca FA, França CN, Ferreira PR, Izar MC, Salomão R, et al. Imbalance between endothelial progenitors cells andmicroparticles inHIV- infected patients naive for antiretroviral therapy. AIDS. 2011;25(13):1595- 601. doi: 10.1097/QAD.0b013e32834980f4. 12. Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al; Sociedade Brasileira de Cardiologia. [IV Brazilian Guideline for DyslipidemiaandAtherosclerosisprevention:DepartmentofAtherosclerosis of Brazilian Society of Cardiology]. Arq Bras Cardiol. 2007 Apr;88 Suppl 1:2-19. doi: http://dx.doi.org/10.1590/S0066-782X2007000700002. 13. Fox C, Evans J, Larson M, Kannel W, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999 - the Framinghamheart study. Circulation. 2004;110(5):522-7. doi: 10.1161/01. CIR.0000136993.34344.41. 14. Schambelan M, Wilson P, Yarasheski K, Cade WT, Dávila-Román V, D’Agostino RB Sr, et al. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. AHA conference proceedings. Circulation. 2008;118(2):e48-53. doi: 10.1161/ CIRCULATIONAHA.107.189627. 15. Hsue PY,Waters DD.What a cardiologist needs to know about patients with human immunodeficiency virus infection. Circulation. 2005;112(25):3947- 57. doi: 10.1161/CIRCULATIONAHA.105.546465. 16. HIV and Cardiovascular Disease: annual update. California: Annenberg Center for Health Sciences at Eisenhower, American Academy of HIV Medicine, Clinical Care Options-HIV; 2010. p. 1-23. 17. Goldberger Z, Valle J, Dandekar V, Chan P, Ko D, Nallamothu B, et al. Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis. Am Heart J. 2010;160(4):701-14. doi: 10.1016/j.ahj.2010.06.029. 18. Grunfeld C, Delaney J, Wanke C, Currier J, Scherzer R, Biggs M, et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study (Fat Redistribution and Metabolic Change in HIV Infection). AIDS. 2009;23(14):1841-9. doi: 10.1097/QAD.0b013e32832d3b85. 19. Hsue P, Lo J, Franklin A, Bolger A, Martin J, Deeks S. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109(13):1603-8. doi: 10.1161/01. CIR.0000124480.32233.8A. 20. Currier JS, Kendall MA, HenryWK, Alston-Smith B, Torriani FJ, Tebas P, et al. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. ACTG 5078 Study Team. AIDS. 2007;21(9):1137-45. doi: 10.1097/QAD.0b013e32811ebf79. 21. Stein J, Korcarz C, Hurst R, Lonn E, Kendall C, Mohler E, et al; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Useofcarotidultrasoundto identifysubclinicalvasculardiseaseandevaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima-media thickness task force endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93-111. doi: 10.1016/j.echo.2007.11.011. 22. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. MannheimCarotid Intima-Media Thickness Consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. CerebrovascDis. 2007;23(1):75-80. doi: 10.1159/000097034. 23. Touboul PJ, Vicaut E, Labreuche J, Belliard J, Cohen S, Kownator S, et al; PARC study participating physicians. Correlation between the Framingham risk score and intima media thickness: the Paroi Artérielle et Risque Cardio-vasculaire (PARC) study. Atherosclerosis. 2007;192(2):363-9. doi: 10.1016/j.atherosclerosis.2006.05.017. 24. Nambi V, Chambless L, Folsom A, He M, Hu Y, Mosley T, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities)study. JAmCollCardiol.2010;55(15):1600-7.doi:10.1016/j. jacc.2009.11.075. 25. Ridker P, Cook N. Clinical usefulness of very high and very low levels of C-reactiveproteinacrossthefullrangeofFraminghamriskscores.Circulation. 2004;109(16):1955-9. doi: 10.1161/01.CIR.0000125690.80303.A8. 26. Koenig W, Löwel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham score - implications for future risk assessment: results from a large cohort study in southern Germany. Circulation. 2004;109(11):1349-53. doi: 10.1161/01. CIR.0000120707.98922.E3. 27. Anjos T, Domingos H, Lopes F. High-sensitivity C-reactive protein in patients withmetabolic syndrome: comparison between patients with AIDS and the general population. Rev Bras Cardiol. 2012; 25(1):19-25. 28. Lau B, Sharrett AR, Kingsley LA, PostW, Palella FJ, Visscher B, et al. C-reactive protein is amarker for human immunodeficiency virus disease progression. Arch Intern Med. 2006;166(1):64-70. doi: 10.1001/archinte.166.1.64 29. Laurent S, Cockcroft J, Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588-605. doi: 10.1093/ eurheartj/ehl254. 30. Mota-GomesMA, Feitosa AM, BrandãoMC, Chaves H. Augmentation index –novopreditorderiscocardiovascular.RevBrasHipertens.2006;13(1):63-4. 31. Nürnberger J, Keflioglu-Scheiber A, Saez A, Wenzel R, Philipp T, Schäfers R. Augmentation index is associated with cardiovascular risk. J Hypertens. 2002;20(12):2407-14. doi: 10.1097/01.hjh.0000045501.82010.fa. 32. Mulders TA, Van den Bogaard B, Bakker A, Trip MD, Stroes ES, Van den Born BJ, et al. Arterial stiffness is increased in families with premature coronary artery disease. Heart. 2012;98(6):490-4. doi: 10.1136/ heartjnl-2011-300999. 33. Brasil. Ministério da Saúde. Pesquisa deOrçamentos Familiares 2008-2009: antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro: IBGE; 2010. 34. Kroll AF, Sprinz E, Leal SC, Labrêa Mda G, Setúbal S. Prevalence of obesity and cardiovascular risk in patients with HIV/AIDS in Porto Alegre, Brazil. Arq Bras Endocrinol Metabol. 2012;56(2):137-41. doi: http://dx.doi . org/10.1590/S0004-27302012000200007. 35. Silva EF, Bassichetto KC, Lewi DS. Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients. Arq Bras Cardiol. 2009;93(2):113-8. doi: http://dx.doi.org/10.1590/S0066- 782X2009000800008. 36. Brasil.MinistériodaSaúde.SecretariadeVigilânciaemSaúde.Departamento deDST, Aids eHepatites Virais. Recomendações para Terapia Antirretroviral em Adultos Infectados pelo HIV - Suplemento II. Brasília; 2010. p.1-28. 37. DepaironM,ChessexS,SudreP,RodondiN,DoserN,ChaveJ,etal;SwissHIV CohortStudy.Prematureatherosclerosis inHIV-infected individuals-focuson protease inhibitor therapy. AIDS. 2001;15(3):329-34. PMID: 11273212. 38. Kingsley L, Cuervo-Rojas J, Munoz A, Palella F, Post W, Witt M, et al. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: multicenter AIDS cohort study. AIDS. 2008;22(13):1589-99. doi: 10.1097/QAD.0b013e328306a6c5. 39. Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV- associated atherosclerosis. AIDS. 2009;23(9):1059-67. doi: 10.1097/ QAD.0b013e32832b514b. 40. Choi A, Li Y, Deeks S, Grunfeld C, Volberding P, Shlipak M. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010;121(5):651-8. doi: 10.1161/ CIRCULATIONAHA.109.898585. 409